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1. Introduction 
Human ehrlichioses and rickettsioses are important arthropod borne infectious diseases 
which are transmitted by ticks, mites, lice and fleas. Infections result in mild to fatal 
outcomes, with clinical presentations that resemble other tropical infectious diseases such as 
malaria making clinical diagnosis difficult. Despite recognition as important causes of life- 
threatening diseases in the United States, the geographic distribution of these diseases 
worldwide remains undefined due to their recent emergence, challenges in diagnosis and 
lack of comprehensive epidemiological studies needed to determine incidence in developing 
countries. Recently, the transfer of  technological developments to other parts of the world 
especially developing countries has encouraged basic epidemiological inquiry and 
generated scientific interest in understanding the epidemiology of these tick borne diseases 
and their role as causes of undifferentiated febrile illnesses. In this chapter, we review the 
current knowledge of human monocytotropic ehrlichiosis (HME) and spotted fever 
rickettsiosis (African tick bite fever) in Cameroon. 
2. Ehrlichiosis 
2.1 Etiologic agents 
Ehrlichioses are diseases caused by small (approximately 0.4–1.5 μm diameter) Gram 
negative, obligately intracellular bacteria belonging to the genus Ehrlichia of the family 
Anaplasmataceae, Order Rickettsiales and the alpha sub-division Proteobacteria (Dumler et 
al., 2001). Although they have a characteristic Gram negative cell wall structure, they lack 
the necessary enzymes to synthesize cell membrane components such as lipopolysaccharide 
and peptidoglycan (Lin & Rikihisa, 2003). As intracellular pathogens, Ehrlichia reside in 
cytoplasmic membrane-bound vacuoles inside host cells (granulocytes or monocytes) 
forming microcolonies called morulae, derived from the Latin word “morus” for mulberry 
(Popov et al., 1995; Paddock et al., 1997; Ismail et al., 2010). These morulae (ranging in size 
from 1.0 to 6.0 µm in diameter) may contain 1 to >40 organisms of uniform or mixed cell 
types (Popov et al., 1995; Rikihisa, 1999). 
Organisms in the family Anaplasmataceae were first described in 1910 when Theiler described 
Anaplasma marginale, the etiologic agent of an economically important and severe disease of 
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cattle (Mahan, 1995). This discovery was followed shortly thereafter by the description of E. 
ruminantium (formerly Cowdria ruminantium) by Cowdry in 1925; E. canis by Donatien and 
Lestoquard in 1935; and A. phagocytophilum (formerly E. phagocytophila) by Gordon in 1940. 
Hence, the genus Ehrlichia was established in 1945 in honour of the German microbiologist 
Paul Ehrlich (Uilenberg, 1983).  
Ehrlichia species cause significant diseases in their natural hosts (livestock and companion 
animals) and emerging zoonoses in humans (McBride & Walker, 2010). The first human 
ehrlichial infection (sennetsu fever) was reported in 1953 ( Rapmund, 1984; Dumler et al., 
2007). Sennetsu fever, caused by Neorickettsia sennetsu, was identified in Japan and Malaysia 
(Dumler et al., 2001; Dumler et al., 2007). However, recent phylogenetic reclassifications 
based on molecular analysis revealed that E. sennetsu is not a member of the Ehrlichia genus 
(Dumler et al., 2001). Presently, the genus Ehrlichia consists of five recognized species 
including E. canis, E. chaffeensis, E. ewingii, E. muris, and E. ruminantium, all of which are at 
least 97.7% similar in 16S rRNA gene sequence (Perez et al., 1996; Paddock et al., 1997; 
Dumler et al., 2001; Perez et al., 2006). 
Ehrlichiae have relatively small genomes (0.8–1.5 Mb) with low G+C content and a high 
proportion of non-coding sequences but can synthesize all nucleotides, vitamins and 
cofactors (Dunning et al., 2006). They also have small subsets of genes associated with host-
pathogen interactions (Ismail et al., 2010). E. chaffeensis have immunodominant outer 
membrane proteins (OMP-1/MSP2/P28) (Ohashi et al., 1998; Yu et al., 2000; Huang et al., 
2008), and in infected macrophages ehrlichiae express the p28-Omp 19 and 20 genes as 
dominant protein products (Ganta et al., 2009; Peddireddi et al., 2009). Ehrlichiae also 
express several targets of the humoral immune response including tandem repeat and 
ankyrin repeat containing proteins (Yu et al., 1997; Sumner et al., 1999; McBride et al., 2003; 
McBride et al., 2007). E. chaffeensis, a human pathogen that was first recognised in the United 
States in 1986 and isolated in 1991 ( Maeda et al., 1987; Dawson et al., 1991) is the cause of 
human monocytotropic ehrlichiosis (HME) (Anderson et al., 1992), a moderate to severe 
disease with a case fatality rate of 3% (Fishbein et al., 1994; McBride & Walker, 2010). E. 
chaffeensis is an obligately intracellular bacterium that primarily infects mononuclear 
leukocytes and replicates by binary fission. E. chaffeensis morulae can be detected in peripheral 
blood smears obtained from infected patients when observed with a light microscope 
(Rikihisa, 1991). When tissues (including clinical samples), mononuclear leucocytes or cell lines 
of mammalian origin infected with  E. chaffeensis are viewed by  electron microscopy, two 
distinct morphologic cell types are identified: a predominantly coccoid form which has a 
centrally condensed nucleoid DNA and ribosomes (dense-cored cells) measuring between  0.4 
and 0.6 µm in diameter and reticulate or the coccobacillary form, which measures about  0.4 to 
0.6 µm by 0.7 to 1.9 µm (Paddock et al., 1995; Popov et al., 1997). 
2.2 Vectors and reservoirs 
Investigative studies following the discovery of E. chaffeensis in the late 1980s revealed that 
the agent is transmitted to humans by the tick Amblyomma americanum, commonly referred 
to as the lone star tick which has a limited geographic distribution to the United States 
(Anderson et al., 1993). Molecular analysis (PCR) has demonstrated E. chaffeensis DNA in 
adult A. americanum ticks collected from different states. The increased recognition of E. 
chaffeensis as an emerging problem has evoked renewed interest in this and other tick borne 
diseases, and this has stimulated epidemiologic investigations of this pathogen and its 
vector in other regions where the tick A. americanum is not found. Results not only indicate 
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that E. chaffeensis has a wider distribution than the United States (Ndip et al., 2010), but also 
indicates that the pathogen exists outside of the known range of A. americanum and is 
harbored by other tick species. These tick species include Ixodes pacificus in California 
(Kramer et al., 1999), Dermacentor variabilis in Missouri (Roland et al., 1998), Ixodes ricinus in 
Russia (Alekseev et al., 2001), Amblyomma testudinarium in China, (Cao et al., 2000), 
Haemaphysalis longicornis (Lee et al., 2003), and Ixodes persulcatus (Kim et al., 2003) in Korea.  
 
 
   (a)                   (b) 
Fig. 1. a) Rhipicephalus sanguineus (brown dog tick) and b) Male Amblyomma variegatum tick 
(courtesy Laboratory for Emerging Infectious Diseases, University of Buea) 
Studies carried out by Ndip and colleagues in Cameroon identified Ehrlichia chaffeensis in 
Rhipicephalus sanguineus ticks. R. sanguineus, commonly known as the brown dog tick 
(Figure 1a) is a species that infests canids worldwide. In one study in Limbe, Cameroon, a 
very high prevalence of E. chaffeensis was detected in R. sanguineus ticks infesting dogs in-
habiting one kennel (Ndip et al., 2010). E. chaffeensis DNA  was detected in 33 (56%) of 63 R. 
sanguineus ticks collected from five dogs as opposed to 4 (6%) ticks infected with E. canis. 
Furthermore, co-infection with more than one pathogen was not uncommon. The E. 
chaffeensis strain circulating in Cameroon is similar to the  North American strain AF403710 
based on the analysis of the 378 bp fragment of the disulphide bond formation (Dsb) protein 
gene (Ndip et al., 2010). Earlier reports revealed E. canis, E. chaffeensis, and E. ewingii in R. 
sanguineus ticks collected from 51 dogs from different localities in Cameroon (Figure 2), 
suggesting that dogs could be a reservoir for E. chaffeensis and that R. sanguineus is the 
probable vector (Ndip et al., 2007). 
In the United States, the white-tailed deer (Odocoileus virginianus) has been recognised as the 
primary natural reservoir of E. chaffeensis (Dugan et al., 2000). However, animals such as 
goats, dogs, and coyotes have also been identified as reservoirs which could play a limited 
role in the transmission of the pathogen to humans (Breitschwerdt et al., 1998; Dugan et al., 
2000; Kocan et al., 2000). Unlike rickettsial species, ehrlichial species are not transmitted 
trans-ovarially (ie., larvae are  uninfected) suggesting that the pathogen is maintained trans-
stadially after the infection is acquired  (Ismail et al., 2010). Although the reservoirs for E. 
chaffeensis in Cameroon have not yet been conclusively identified, preliminary studies 
detected antibodies reactive to E. chaffeensis in 56% of goats analysed suggesting a probable 
role of goats in maintaining the pathogen in nature. Moreover, E. chaffeensis DNA was 
detected in 17% of ticks collected from these animals (Ndip, unpubished data).  
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Fig. 2. Known distribution of ehrlichiae and rickettsiae in Cameroon 
2.3 Clinical manifestations 
The comprehensive data available in literature today on symptoms observed in HME 
infection is based on cases reported to the United States’ Centers for Disease Control and 
Prevention in addition to a series of patients studied since the disease was described. After 
exposure to an infecting tick, an incubation period of 1 to 2 weeks (median, 9 days) ensues 
after which patients develop a febrile illness (often >39°C) characterized by general malaise, 
low-back pain, or gastrointestinal symptoms (Paddock & Childs, 2003). These signs and 
symptoms most often resemble manifestations caused by other infectious and non-infectious 
causes. After 3 to 4 days, symptoms progress and patients may seek medical attention 
presenting with fever (>95%), headache (60 to 75%), myalgias (40 to 60%), nausea (40 to 
50%), arthralgias (30 to 35%), and malaise (30 to 80%) (Fishbein et al., 1994).  
Some patients (10-40%) may present with cough, pharyngitis, diarrhea, or abdominal pain 
and may even progress to changes in mental status (Fishbein et al., 1994; Olano et al., 2003). 
Some populations especially HIV-infected patients (Paddock et al., 2001) and children 
(Jacobs & Schutze, 1997) may develop a rash on the extremities, trunk and face (Edwards, 
1991). Hematological changes include leukopenia in approximately 60 to 70% of patients 
and thrombocytopenia (Fishbein et al., 1994; Olano & Walker, 2002). Liver enzymes (hepatic 
transaminases) may become slightly elevated (Nutt & Raufman, 1999). About 60 to 70% of 
patients require hospitalization and untreated cases last for 2-3 weeks or progress to a fatal 
outcome during the second week (Fishbein et al., 1994; Standaert et al., 2000). About 20% of 
patients develop neurologic signs, cough or other respiratory symptoms  (Fishbein et al., 
1994; Olano et al., 2003). Case-fatality ratio is approximately 3% (McQuiston et al., 2003) 
with risk factors for severe or fatal disease including older age (Paddock et al., 2001), 
underlying debilitating diseases such as HIV infection, immunosuppressive therapies  
(Olano & Walker, 2002) and sickle cell disease (Paddock & Childs, 2003).  
These reported symptoms are quite similar to those manifested by Cameroonian HME 
patients. In one series of 206 acutely ill patients studied, 30 (14.6%) demonstrated anti-
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ehrlichial IgM antibodies, and these probable HME patients presented with headache (83%), 
fatigue (37%), abdominal pain (47%), joint pain (60%), anorexia (37%) and diarrhoea (13%) 
in addition to fever (>38oC). Their mean hematocrit, AST and ALT values were 48±21%, 
46±23% and 36± 21%, respectively. Five (17%) of the patients were anaemic while 10 (33%) 
and 5 (17%) had abnormal AST and ALT values, respectively (Ndip, unpublished data). In 
another series of 118 acutely ill febrile patients studied with HME diagnosed by detection of 
E. chaffeensis DNA in patient’s blood (n=12), these patients presented with fever (100%), 
headache (seen in 72% of the patients), arthralgia (58%), myalgia (42%), cough (17%) and a 
diffuse maculopapular rash (17%). The rash was present on the trunk of one patient and the 
arms of another. One patient of the 12 with detectable E. chaffeensis DNA required 
hospitalization (see Table 1) (Ndip et al., 2009). 
2.4 Epidemiology 
The epidemiology and ecology of HME worldwide is not well documented. Since its 
description in 1986 more than 1000 cases of HME from at least 30 U.S. states have been 
reported to the Centers for Disease Control and Prevention in Atlanta, Georgia with 
nearly all occurring in the southeastern and south-central United States where the 
vector, A. americanum is common (Paddock & Childs, 2003; Dumler et al., 2007). 
However, the evidence of the disease and/or the pathogen is increasingly being 
reported in other parts of the world. This includes Africa (Uhaa et al., 1992; Brouqui et 
al., 1994; Ndip et al., 2009; Ndip et al., 2010), Israel (Dawson et al., 1991; Keysary et al., 
1999; Brouqui & Dumler, 2000), Latin America (Gongora-Biachi et al., 1999; Calic et al., 
2004;) and Asia (Heppner et al., 1997; Cao et al., 2000; Heo et al., 2002; Kim et al., 2003; 
Park et al., 2003, Lee & Chae, 2010). 
In Cameroon, HME has been identified in patients along the coast of Cameroon, in Buea 
(4o10’0’’N9o14’0’’E), Limbe (4o01’N 9o13’13’’E), Muyuka (4o43’18’’N 9o38’27’’E), Tiko 
(4o4’0’’N 9o22’60’’E), and Kumba (4o38’38’’ N9o26’19’’E) and the agent, E. chaffeensis, in 
ticks collected from Limbe (Figure 2). HME was observed in both males and females as 
well as in children and adults although results suggested that older age was a risk factor 
for the disease (Ndip et al., 2009). The majority of the patients were adults which 
suggests that exposure to infected ticks may have occurred during outdoor activities 
such as farming. Another risk factor is that of owning a companion or domestic animal 
since most Cameroonian HME patients indicated they had tick-infested pets and 
domestic animals.  
2.5 Microbiological diagnosis 
The diagnosis of HME requires specialized microscopy equipment and skills which are not 
readily available in many diagnostic laboratories. Several methods have been proposed for 
the diagnosis of HME (Paddock & Childs, 2003; Ismail et al., 2010),  including serologic tests 
such as immunofluorescent assay (IFA), western immunoblot employing specific proteins or 
ehrlichial whole cell antigens or the recently developed Ehrlichia recombinant protein or 
peptide ELISA for detection of the antibody (Cardenas et al., 2007; Luo et al., 2010; O'Connor 
et al., 2010). Though these tests can be used to confirm diagnosis retrospectively, some 
patients may not sero-convert during the early days of the disease and cannot be diagnosed 
with serologic tests. However, collecting paired sera (at acute and convalescent phases of 
illness) is confirmatory as a four-fold rise in titer indicates current infection. However, this 
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always presents a problem because patients who recover may not return to the hospital for 
follow up. Moreover, another issue with the interpretation of serological tests such as IFA is 
cross-reactive antibodies against other organisms, including Anaplasma species. PCR has 
also been employed to identify ehrlichial DNA in acutely ill patients when antibodies have 
not reached detectable levels. Several genes have been proposed and used including the 
VLPT gene (TRP32), TRP36, 16S rRNA, the TRP120, the Dsb, 28-kDa outer membrane 
protein gene have been used as genus or species specific targets (Yu et al., 1999; Doyle et al., 
2005). IFA, western blot and PCR have been used to study the prevalence of ehrlichiae in 
blood of acutely ill patients, reservoirs, or in suspected tick vectors and anti-ehrlichial 
antibody in sera (Ndip et al., 2005; Ndip et al., 2007; Ndip et al., 2009; Ndip et al., 2010). 
Figure 3 shows IFA photomicrographs of whole cell of E. chaffeensis reacting with antibodies 
in an HME patient serum. A rapid method to detect E. chaffeensis is the observation of 
morulae in smears of peripheral blood buffy coat using the Diff Quik or Giemsa stain. 
However, this technique is very insensitive, and morulae are detected in leukocytes in only 
10% of HME patients. 
 
Patients 1 2 3 4 5 6 7 8 9 10 11 12 
             
 Gender F F M F M M F M F F M M 
Age (yr) 63 40 5 23 22 20 21 1 16 26 35 25 
Location A B C D C D A C A A B A 
Clinical 
Manifestations 
           
Fever >38oC Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
*Day(s)  6 8 4 7 4 3 1 1 2 7 2 2 
Headache Yes Yes Yes No No Yes Yes No Yes Yes Yes No 
Myalgia Yes Yes No No No Yes No No Yes No Yes No 
Arthralgia Yes Yes No No No Yes Yes No Yes Yes Yes No 
Rash No No No Yes No No No Yes No No No No 
*Days after onset (i.e., before collection of sample).  
Locations: A - Buea , B – Limbe, C – Tiko, D - Muyuka 
Table 1. Epidemiologic and clinical characteristics of twelve Cameroonian patients with HME 
2.6 Treatment 
The drug of choice for the treatment of E. chaffeensis infection is the tetracyclines 
(particularly doxycycline) and their derivatives. Generally, between 1 and 3 days after a 
patient with HME commences treatment with doxycycline, the patient becomes afebrile 
(Olano & Walker, 2002). However, treatment may continue for up to 10 days or at least 3 
days after the patient becomes afebrile (Chapman et al., 2006). Clinical experience and in-
vitro susceptibility testing of E. chaffeensis to some classes of antibiotics have revealed that 
fluoroquinolones, penicillins, aminoglycosides, macrolides and cotrimoxazole are not 
effective therapeutics (Dumler et al., 1993; Brouqui et al., 1994; Brouqui & Raoult, 1994; 
McBride & Walker, 2010). 
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            A       B 
Fig. 3. Reactions of patient serum with Ehrlichia chaffeensis antigen and staining with 
Fluorescein isothiocynate (FITC)-labelled goat, IgG anti-human antibody (X40 
magnification). A: Negative IFA slide, no inclusion bodies in cells. B: Positive IFA slide with 
morulae in monocytes (arrows) (Courtesy Laboratory for Emerging Infectious Diseases, 
University of Buea). 
3. Rickettsiosis 
3.1 The Genus Rickettsia 
Rickettsial organisms are Gram-negative bacteria belonging to the order Rickettsiales, 
Family Rickettsiaceae and the Genus Rickettsia. They are strict intracellular parasites that are 
transmitted by arthropods including fleas, lice, mites and ticks (Kelly et al., 1992). These 
organisms are typically short rods (coccobacilli) measuring about 0.8-2.0µm in length and 
0.3-0.5µm in diameter. They exhibit most of the biochemical and morphological 
characteristics of the Gram-negative cell (Gimenez, 1964; La Scola & Raoult, 1997). Based on 
antigenic characteristics, species of the genus Rickettsia have been divided into three groups; 
namely the typhus group (TG), the spotted fever group (SFG) and the transitional group 
(TRG). The TG has two members (R. prowazekii and R. typhi), which are mainly transmitted 
by lice and fleas, respectively (Raoult & Roux, 1997). The largest of the antigenic groups is 
the SFG that is made up of the tick-transmitted pathogens (except R. bellii and R. canadensis) 
(Parola et al., 2005). It has been grouped into several genogroups based on the 16S rRNA, the 
gltA, ompA, ompB and sca2 sequences. These groups include the R. rickettsii group, the R. 
massiliae group and R. helvetica group. The transitional group includes R. akari, R. australis, 
and R. felis. There are many ancestral organisms including R. canadensis and R. bellii (Parola 
et al., 2005), as well as numerous rickettsiae in herbivorous insects, and other hosts (leaches 
and amoeba). Also in the family Rickettsiaceae is Orientia tsutsugamushi, which is 
transmitted by Leptotrombidium deliense (Tamura et al., 1995). 
Rickettsial organisms are of worldwide occurrence, although species/vector differences may 
exist along various geographical lines. In Africa, several species have been reported. These 
include R. conorii Malish strain, the cause of Mediterranean spotted fever or “boutonneuse 
fever”. It was first documented in Tunis (Conor & Bruch, 1910), and today the disease 
continues to be reported in Tunisia (Romdhane et al., 2009; Sfar et al., 2009) and South 
Africa. The infection has the characteristic of a papular rash, in addition to an eschar at the 
site of the tick bite (Anton et al., 2003). The pathogen is transmitted by R. sanguineus ticks, 
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and is considered an urban disease (Font & Segura, 1983). Human infections with another 
strain of R. conorii (Israeli spotted fever strain) have been recently documented in Tunisia 
(Znazen et al., 2011). R. conorii Astrakhan strain is the cause of Astrakhan fever first detected 
in Astrakhan, Russia in the 1970s and transmitted by R. sanguineus and R. pumilio ticks 
(Parola et al.,  2005). The Astrakhan strain has also been isolated from a patient in Chad 
(Fournier et al., 2003). R. sibirica mongolitimonae strain was identified in Hyalomma 
truncatum ticks in Niger in 2001 (Parola et al., 2001) and the first human case in Africa was 
documented in South Africa (Pretorius & Birtles, 2004). Other cases have been reported to 
have been acquired in Algeria (Fournier et al., 2005) and Egypt (Socolovschi et al., 2010). 
Another species, R. aeschlimannii, which was first isolated in H. marginatum ticks in Morocco 
(Beati et al., 1997) and later detected in H. marginatum rufipes in Mali and Niger, have been 
known to cause infections in tourists returning from Morocco and South Africa (Parola et al., 
2001). R. massiliae, first isolated from R. sanguineus ticks in Marseille, France (Parola et al., 2005) 
was detected in R. muhsame, R. lunalatus and R. sulcatus from Central African Republic 
(Dupont et al., 1994) and  in R. muhsame ticks collected from cattle in Mali  2001) and Ivory 
Coast  (Berrelha et al., 2009). Rickettsia felis is a recently identified pathogen which was first 
detected in Ctenocephalides felis fleas (Bouyer et al., 2001). In Africa, the agent has been reported 
in Ivory Coast (Berrelha et al., 2009) and Senegal (Socolovsch et al., 2010), and human 
infections have been reported in Kenya  (Richards et al., 2010). Rickettsia africae, the etiologic 
agent of African tick bite fever appears to be the most prevalent rickettsiosis in Africa. The 
disease was first reported in Mozambique and South Africa (McQuiston et al., 2004). The first 
isolate (R. africae strain ESF-5), was recovered from A. variegatum ticks in Ethiopia  although it 
was only characterized as R. africae later (Roux et al., 1996). The agent was later isolated in A. 
hebraeum ticks in Zimbabwe in 1990, and in 1992, the first isolate from a patient was obtained 
(Kelly et al., 1991; Kelly et al., 1994). The pathogen has been detected in many other African 
countries including Senegal (Mediannikov et al., 2010),  Ethiopia (Stephany et al., 2009) and 
Cameroon  (Ndip et al., 2004a; Ndip et al., 2004b). In the following, we give a synopsis of our 
current knowledge of African tick bite fever in Cameroon. 
3.2 Causative organism  
R. africae, a member of the SFG is the only species that has been detected in Cameroon. The 
organism which measures about 0.4 µm by 1.0 µm, has an outer slime layer and a trilaminar 
cell wall which contains immunogenic lipopolysaccharide antigens responsible for cross-
reactivity with the other SFG rickettsiae (Hechemy et al., 1989; Kelly et al., 1996). Like other 
Gram-negative organisms, rickettsiae have outer membrane proteins (dubbed OmpA and 
OmpB) present as species-specific antigens (Fournier et al., 1998; Roux & Raoult, 2000). The 
organism lives freely in the cytoplasm and usually infects endothelial cells. According to 
phylogenetic studies, this rickettsial species, which belongs to the R. rickettsii group is closely 
related to R. parkeri in North America and R. sibirica in northeast Asia (Parola et al., 2005). 
3.3 Tick vectors and reservoirs 
R. africae is a tick-borne pathogen, and ticks serve both as vectors and reservoirs. The 
pathogen is maintained in the tick through trans-stadial and trans-ovarial transmission, 
and this situation indicates the potential for transmission to humans by all stages (larvae, 
nymphs, and adults) of the feeding ticks. Ixodid ticks (hard ticks) of the genus Amblyomma 
have been recognized as the vectors (Kelly, 2001). In Cameroon, A. variegatum (Figure 1b) 
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has been identified as the potential vector with about 75% of ticks (male and female) 
collected from cattle found to be infected with R. africae  (Ndip et al., 2004b). Reports from 
other studies have indicated that R. africae infection in Amblyomma ticks frequently has a 
high prevalence (up to 100%) reported in ticks collected in some disease-endemic 
countries (Dupont et al., 1994; Parola et al., 2001). Like any other tick borne disease, the 
ecological characteristics of the vector influence the epidemiology of the disease. The ticks 
are usually found all year round, but they peak during and after the rainy season when 
humidity is very high (Walker et al., 2003). Ambylomma are predominantly cattle ticks, and 
infestation of cattle can be very high (Kelly & Mason, 1991). A. variegatum, commonly 
found in central and west Africa typically enjoys a wide variety of different habitats 
although they have a preference for semi-arid and humid areas with tall grass, trees, 
and/or bush cover. These ticks usually quest on vegetation and would usually attack legs 
although they may crawl to other areas such as groin and perineum where they attach 
(Jensenius et al., 2003).  
3.4 Clinical presentation  
Since the description of ATBF in 1992, most of the knowledge available regarding the 
disease has been documented in travelers who become infected with R. africae during travel 
in Africa. After inoculation from a tick bite, the bacteria invade the vascular endothelial 
system causing a focal or disseminated vasculitis. Endothelial cells of small blood vessels 
become infected leading to the destruction of the endothelial cells (Toutous-Trellu et al., 
2003) of the host where they have multiplied and eventually injured the host cells, leading to 
the disease symptoms. Multiple eschars typical of ATBF develop at the sites of tick bite, and 
following an incubation period between 5 and 7 days (up to two weeks in some cases), after 
the tick bite a febrile illness develops (Raoult et al., 2001). In most cases, symptoms of ATBF 
are usually mild and include headaches, nausea, chills, myalgia, lymphadenopathy and 
prominent neck ache (Jensenius et al.,  2003; Raoult et al., 2001). Although there have been 
some controversies over the differences in the clinical presentations of African tick bite 
fever, our study of acutely ill patients in Cameroon revealed that the some individuals may 
manifest severe symptoms while in others the symptoms are mild. However, symptoms 
reported include fever >38°C (100%), headache (71%), myalgia (71%), arthralgia (57%), rash 
(15%) and pulmonary signs (28%).  
3.5 Epidemiology 
ATBF has been recognized as an emerging problem in sub-Saharan Africa, especially for 
international travelers to rural areas (Jensenius et al., 2003). Most of the victims reported are 
tourists who visit game reserves or participate in outdoor activities such as running, 
trekking and hiking in forested areas, usually inhabited by Amblyomma ticks. The patients 
acquire the disease in rural Africa, but most often symptoms manifest only after they have 
returned to their various countries in Europe and America. The first report suggesting that 
rickettsiosis could be prevalent in Cameroon was published in 1968 (Maurice et al., 1968). 
The report based on a serologic survey that used an unreliable technique demonstrated 
rickettsial antibodies in cattle and humans in the northern region of Cameroon and in other 
animals in the south of the country ( Maurice et al., 1968; Le et al., 1977). Efforts to determine 
the epidemiology and ecology later re-emerged in 2004 when anti-rickettsial IgM antibodies 
were detected in some Cameroonian patients along the coastal region of Cameroon (Ndip et 
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al., 2004a). These results were further confirmed by detection of R. africae DNA in about 6% 
of acutely ill febrile patients  (Ndip et al., 2004b). Human infections or the agent has been 
detected in all regions of southern Cameroon where epidemiologic investigations have been 
made (Figure 3). According to these studies, age appeared to be a risk factor of acquiring the 
disease, and it is suggested that activities such as game hunting usually constitutes a risk 
factor (Ndip et al., 2011). Other activities which could predispose to infection include cattle 
rearing and exposure to tick habitats.  
Cameroon is a sub-saharan tropical country with a vast equatorial forest providing a good 
habitat for ticks (especially A. variegatum ticks). Individuals residing in lowland rainforest 
habitats have a higher risk of acquiring ATBF probably because these habitats are ideal for 
A. variegatum ticks because of their moderate canopy cover, providing microclimates 
favoring tick survival (Ndip et al., 2011). Although ATBF has been shown to be prevalent in 
the southern part of Cameroon (Figure 2), the actual epidemiology of the disease through 
wider disease surveillance needs to be documented. 
3.6 Diagnosis  
Diagnosis of ATBF can be achieved by either serological analysis of acute and convalescent 
serum samples or molecular detection of the DNA of the bacterium by real-time or 
conventional PCR. Target genes that have been utilized include the rickettsial gltA and ompA 
genes. For serological diagnosis, the indirect immunofluorescent test has been used in 
conjunction with western blot assay to detect antibodies reactive with whole cells or specific 
proteins of cell lysates of R. africae. However, these tests are not very reliable in 
distinguishing species because cross-reactivity may be observed among the SFG rickettsiae. 
However, some authors have proposed that a fourfold or greater titer for R. africae 
compared to other species is confirmatory (Raoult et al., 2001; Ndip et al., 2004a). The 
western immunoblot assay can also be used to detect antibodies against species-specific 
OmpA and OmpB proteins. 
3.7 Treatment  
The drug of choice for the treatment of ATBF is doxycycline (100 mg twice daily) for 3-7 
days. In-vitro studies also indicate that R. africae is susceptible to tetracyclines, 
fluoroquinolones, some macrolides and chloramphenicol (Rolain et al., 1998). Mild cases of 
ATBF have also been shown to recover naturally (Jensenius et al., 1999). 
4. Prevention of ehrlichiosis and rickettsiosis 
Studies in Cameroon indicate that one risk factor for contracting E. chaffeensis infection and 
ATBF appears to be exposure to potential tick vectors. Many reports involving acquisition of 
rickettsial diseases have also indicated that exposure to ticks during safari tours and visit to 
parks constitute an important risk factor. Therefore, an important method of preventing 
ehrlichiosis and rickettsiosis is by reducing contact with infected ticks. Personal protective 
measures are quite important, including wearing light colored clothes when walking in tick 
infested areas, using insect repellents and examination of clothing after a visit to a tick 
infested area, and prompt removal of attached tick can all reduce the risk of infection. 
Companion animals and other domesticated animals should be taken care of and tick 
infestation controlled.  
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4.1 Conclusions 
These data emphasize the importance of ehrlichiosis and ATBF as prevalent diseases in an 
indigenous Cameroonian population. Although these diseases present as febrile illnesses, 
they are rarely considered when evaluating patients with acute, undifferentiated febrile 
illnesses. This situation can be attributed in part to lack of adequate knowledge of the 
epidemiology and ecology of the disease to prompt diagnosis; unavailability of specific 
laboratory tests, equipment, and expertise and also the limited economic resources. Sharing 
new knowledge on these diseases and techniques to facilitate diagnosis are important 
factors that can change the types and frequencies of diseases diagnosed in febrile patients 
and necessitate surveillance for these diseases. Future efforts will attempt to address other 
issues requiring investigations such as the full description of the clinical spectrum of these 
diseases in African patients and risk factors for severe illness.  
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